Publications by authors named "S Gertler"

Photonic design is a process of mathematical optimization of a desired objective (beam formation, mode conversion, etc.) subject to the constraint of Maxwell's equations. Finding the optimal design is challenging: Generically, these problems are highly nonconvex and finding global optima is NP hard.

View Article and Find Full Text PDF

New strategies for converting signals between optical and microwave domains could play a pivotal role in advancing both classical and quantum technologies. Traditional approaches to optical-to-microwave transduction typically perturb or destroy the information encoded on intensity of the light field, eliminating the possibility for further processing or distribution of these signals. In this paper, we introduce an optical-to-microwave conversion method that allows for both detection and spectral analysis of microwave photonic signals without degradation of their information content.

View Article and Find Full Text PDF

The growing demand for bandwidth makes photonic systems a leading candidate for future telecommunication and radar technologies. Integrated photonic systems offer ultra-wideband performance within a small footprint, which can naturally interface with fiber-optic networks for signal transmission. However, it remains challenging to realize narrowband (∼MHz) filters needed for high-performance communications systems using integrated photonics.

View Article and Find Full Text PDF

The canonical beam splitter-a fundamental building block of quantum optical systems-is a reciprocal element. It operates on forward- and backward-propagating modes in the same way, regardless of direction. The concept of nonreciprocal quantum photonic operations, by contrast, could be used to transform quantum states in a momentum- and direction-selective fashion.

View Article and Find Full Text PDF
Article Synopsis
  • The NRG Oncology/RTOG 9802 study demonstrated that patients with WHO low-grade glioma benefit from adjuvant chemoradiotherapy, showing improved survival compared to radiotherapy alone.
  • A post hoc analysis evaluated the impact of molecular subgroups on patient outcomes, finding significant differences in progression-free survival (PFS) and overall survival (OS) based on molecular mutations.
  • Specifically, treatment with postradiation chemotherapy (PCV) significantly improved PFS and OS for mutant groups, while showing no benefit for patients in the wild-type subgroup, highlighting the importance of molecular profiling in treatment decisions.
View Article and Find Full Text PDF